|
NCI Press Materials
Largest-Ever Prostate Cancer Prevention Trial Opens: 32,000 Men Sought to Test Vitamin E and Selenium
(Posted: 07/24/2001) - Healthy men age 55 and older are needed for the largest-ever prostate cancer prevention study, launched today by the NCI and a network of researchers known as the Southwest Oncology Group (SWOG).
Se inagura estudio de prevención de cáncer de próstata
(Posted: 07/24/2001) - Más de 400 centros en los Estados Unidos, Puerto Rico y Canadá están aceptando participantes para SELECT. Este estudio durará 12 años. SELECT es el primer estudio diseñado para observar directamente los efectos del selenio y la vitamina E, tanto juntos como por separado, para prevenir el cáncer de próstata.
Questions and Answers: SELECT (Selenium and Vitamin E Cancer Prevention Trial)
(Posted: 07/24/2001) - SELECT stands for the Selenium and Vitamin E Cancer Prevention Trial, which is a clinical trial to see if one or both of these dietary supplements prevent prostate cancer in men
Preguntas y respuestas: SELECT (Estudio del Selenio y la Vitamina E para Prevenir el Cancer)
(Posted: 07/24/2001, Updated: 04/29/2003) - SELECT, el Estudio del Selenio y la Vitamina E para Prevenir el Cáncer, es un estudio clínico para determinar si uno o ambos suplementos dietéticos previenen el cáncer de próstata.
Best Leads for Prostate Cancer Prevention Appear in April Urology Supplement; Agents, Biomarker Endpoints, Cohorts, and Trial Designs Outlined
(Posted: 04/09/2001) - The most promising agents to prevent prostate cancer and the most likely biological markers of risk for the disease are just two of the key areas of prostate cancer prevention research highlighted.
< Previous Section | Next Section > |
